In Focus: Spectacle lenses that slow myopia progression

A new lens developed by Essilor designed to slow the progression of myopia in children has been heralded as a ‘game changer’ following a year-long clinical trial.

Essilor said the Stellest ophthalmic lens could slow down myopia progression by 60% on average when compared to children wearing single vision lenses.

The company said the results presented strong evidence of its lenses’ effectiveness and promise to become a solution to myopia progression.

A total of 167 myopic children aged between eight and 13 years old were involved in a one-year interim clinical trial and were divided into a treatment group who wore the Stellest lens and a control group with single vision lenses.